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Abstract
Background: Congenital contractural arachnodactyly (CCA) is an autosomal dominant rare genetic disease, estimated
to be less than 1 in 10,000 worldwide. People with this condition often have permanently bent joints (contractures),
like bent fingers and toes (camptodactyly).
Case presentation: In this study, we investigated the genetic aetiology of CCA in a four-generation Chinese family.
The blood samples were collected from 22 living members of the family in the Yangquan County, Shanxi Province,
China. Of those, eight individuals across 3 generations have CCA. Whole exome sequencing (WES) identified a missense
mutation involving a T-to-G transition at position 3229 (c.3229 T > G) in exon 25 of the FBN2 gene, resulting in a Cys 1077
to Gly change (p.C1077G). This previously unreported mutation was found in all 8 affected individuals, but absent in 14
unaffected family members. SIFT/PolyPhen prediction and protein conservation analysis suggest that this novel mutation
is pathogenic. Our study extended causative mutation spectrum of FBN2 gene in CCA patients.
Conclusions: This study has identified a novel missense mutation in FBN2 gene (p.C1077G) resulting in CCA in
a family of China.
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Background
CCA, also known as Beals-Hecht syndrome, is an auto-
somal dominant disorder of connective tissue. It was
first described by Epstein et al. in 1968, and then was
differentiated from Marfan syndrome (MFS) by Beals
and Hecht in 1971 [1–3]. MFS and CCA share numer-
ous common characteristics, such as a so-called marfa-
noid appearance constituted by tall, slender, asthenic
appearance and skeletal features such as arachnodactyly,
dolichostenomelia, pectus deformities, and kyphoscoliosis.
In contrast with MFS, most individuals with CCA have
“crumpled” ears, flexion contractures, and muscular
hypoplasia.
Up to today, FBN2 is the only gene known to be asso-
ciated with CCA [4, 5]. The FBN2 gene makes fibrillin-2
protein [6]. Fibrillin-2 is related to the elasticity of the
tissue and plays a key role in the formation of extracellu-
lar microfibrils in elastic fiber providing strength and
flexibility to connective tissue that supports the body’s
joints and organs. Mutations in the FBN2 gene can
decrease fibrillin-2 production or result in the produc-
tion of a fibrillin-2 protein with abnormal function.
FBN2 is expressed early in embryogenesis in elastic car-
tilage, aortic tunica media and bronchial epithelium [7].
FBN2 deficient mice have forelimbs contractures, bilat-
eral syndactyly and disorganized microfibrils [8].
As of September 5, 2016, 63 FBN2 mutations have
been described in 72 probands/families with CCA [6].
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Because FBN2, located at 5q23.3, is a very large gene
containing 65 exons and encoding 2912 amino acids, we
thought many more mutations causative to CCA have
yet to be identified. Here, we report a novel missense
mutation in FBN2 gene identified by whole exome
sequencing in a four-generation CCA family.
Case presentation
The subjects of the study were 22 living members from
a four-generation family affected with CCA living in the
Yangquan County, Shanxi Province, China. The study
was reviewed and approved by the institutional ethics
committee of the Shanxi Population and Family
Planning Research Institute in Shanxi, China. A written
informed consent was obtained from the subjects before
study. 7 ml peripheral venous blood was collected from
8 CCA patients (II-3, II-5, II-7 III-3, III-4, III-5. III-7,
IV-1) and 15 normal subjects (II-1, II-2, II-4. II-6. II-8,
II-9, II-10, II-11, II-12, III-1, III-2, III-6, III-8, III-9, III-10)




Genomic DNA was extracted from the blood samples
using a DNA isolation kit for mammalian blood
(Tiangen Biotech, China) according to manufacturer’s
instructions. The integrity of DNA was evaluated using
an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo
Alto, CA, USA) and purity/concentration was deter-
mined using a NanoDrop 8000 Spectrophotometer
(Thermo Scientific, Wilmington, DE, USA).
Sequencing and analysis
Whole exome sequencing was performed using Roche
NimbleGen SeqCap EZ V3.0 System according to the
manufacturer’s instruction. Briefly, 1ug of genomic DNA
was sheared, size selected to roughly 300 bps. DNA
library was made using Kapa LTP library preparation kit,
followed by incubation with SeqCap biotinylated DNA
baits. After an amplification of 14 cycles, the libraries
were sequenced at 2X100 on a HiSeq 2500 sequencer.
The raw sequence data were aligned to the GRCh37
human reference genome using BWA v0.7.7-r411. PCR
duplicates were marked using Mark Duplicates program
in Picard-tools-1.115 tool set. GATK v3.2-2 and
Samtools were used for the identification of INDEL and
the SNVs, respectively. All variants were annotated using
the Annovar program. FBAT (family based associated
test) was used to identify SNPs that are significantly
associated with CCA at the p value of 0.05.
Results
Clinical features of the patients
The studied family has 25 members across four genera-
tions. Three of those were deceased (Fig. 1). A detailed
physical examination was taken for 22 living members
when samples were collected. Eight living members of
the family have a typical CCA phenotype (II-3, II-5, II-7,
III-3, III-4, III-5, III-7, IV-1) as presented with slender,
contractural clubbed fingers and toes (Fig. 2). III-5 was
the proband of 28 years old (at birth with clenched pos-
ition of hands and 300 of myopia). No neurological, car-
diovascular abnormalities, external ear malformation or
eye abnormality were noted. Intrafamilial variation in
phenotypic expression are modest.
Mutation analysis
To reconcile clinical findings with molecular data in this
family, whole exome sequencing was performed for all
22 living members with an Illumina Hiseq2500 sequen-
cer. All samples were sequenced to a mean target cover-
age of >50x, and had a quality score of > Q30 for more
than 85% of bases. After identification of all variant calls,
FBAT analysis was used to identify variants that were
significantly associated with CCA phenotype at p <0.05.
Fig. 1 Pedigree of the family that took part in this study. The patients with congenital contractural arachnodactyly are depicted by black symbols.
The arrow indicates the proband. The squares denote males and circles denote females. Crossed lines indicate deceased family members
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Of those variants, heterozygous mutation, T3229G
(chr5_127680191, p.C1077G) in FBN2 gene, was the
most significant one. This novel missense mutation was
100% co-segregated with the disease in the family and
was absent in 14 unaffected members. C1077G mutation
has a CADD PHRED score of 23.4. All six functional
prediction tools (SIFT, PolyPhen-2, Mutation Taster,
Mutation Assessor, FATHMM and FATHMM MKL
Coding) predicted this mutation as damaging. Consist-
ently, amino acid conservation analysis (http://geno
me.ucsc.edu) showed that the cysteine at position 1077
(p.C1077) is highly conserved across multiple species
(Fig. 3). This mutation is also confirmed by Sanger
sequencing (Fig. 4).
This variant was neither reported in global scale initia-
tives for variant annotation such as the Exome Aggregation
Consortium (ExAC) nor described in the UMD-FBN2 data-
base. However, one mutation located at the same amino
acid position (p.Cys1077Arg) was documented in UMD-
FBN2 database (reported as FRA01BOU F0061 I0092).
Interestingly, the phenotype of this patient was also limited
to joint contractures but with crumpled ears.
We also found a missense mutation in FNIP1 gene, in-
volving a A-to-G transition at position 2446 (p.I816V) in
Fig. 2 CCA phenotypes of eight affected family members. The photos of clubbed fingers from II-3, II-5, II-7, III-3; III-4, III-5, III-7 and IV-1 were taken
when the samples were collected
Fig. 3 Protein sequencing alignment showing conservation of cysteine residue at the position 1077 in FBN2 gene
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exon13, which was also 100% present in CAA patients
and absent in all normal members in this family.
Discussion
CCA is an established autosomal dominant genetic disease
[9] characterized by contractures, arachnodactyly, dolichos-
tenomelia, scoliosis, crumpled ears and pectus deformities
[10]. The clinical symptoms are similar, but genetically dis-
tinct, to MFS. Mutations of FBN2 gene cause CCAand mu-
tations in the FBN1 gene result in MFS. However, MFS is
genetically heterogeneous as it can be related to mutations
in FBN1, TGFBR2 and TGFBR1 genes [11].
FBN2 gene is located in chromosome 5q23-q31 and con-
tains 65 exons, coding fibrillin-2 (2912 amino acids) [6].
For such a large gene, there are relatively small number of
mutations that have been identified so far. As of May 20,
2016, ClinVar only recorded 336 mutations, of which 51
were considered as pathogenic by HGMD Professional
database. Fifty-four percent of those pathogenic mutations
are missense mutations, frequently replacing the Cysteine
with another amino acid. The substitution of another
amino acid for Cysteine can alter the structure or function
of fibrillin-2 [12, 13]. All of these mutations reduce the
amount of fibrillin-2 available to form microfibrils.
Decreased microfibril formation will weaken the elasticity
of fibers, which leads to the symptoms of CCA [14].
In this study, we found a novel missense mutation involv-
ing a T-to-G transition at position 3229 (c.3229 T >G) in
exon 25 of FBN2, resulting in a Cys 1077 to Gly change
(p.C1077G). Cys 1077 is highly conserved across many dif-
ferent species, suggesting it is required for the function of
the protein. As expected, this mutation was predicted to be
deleterious by SIFT and PolyPhne-2 software. Thus, this
novel mutation is likely the genetic cause of CCA in this
family.
Another missense mutation (rs7717874) in FNIP1
gene, 100% co-segregated with CCA, has so far not been
associated with any disease. It was predicted to be be-
nign with a score of 0.002 (sensitivity: 0.99; specificity:
0.30) by PolyPhen-2. FBN2 and FNIP1 are only 310 kb
apart, and thus the association between CCA and FNIP1
mutation is likely due to the linkage disequilibrium.
However, we cannot rule out a possibility that FNIP1
gene has a regulatory role in the clinical expression of
CCA.
Conclusion
This study has identified a novel missense mutation in
FBN2 gene (p.C1077G) resulting in CCA in a family of
China. The role of missense mutation at position 2446
(p.I816V) in FNIP1 gene is worthy of further investigation.
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